227 related articles for article (PubMed ID: 2454355)
1. The effect of low dose carvedilol on circadian variation of blood pressure in patients with essential hypertension.
Ogihara T; Ikeda M; Goto Y; Yoshinaga K; Kumahara Y; Iimura O; Ishii M; Murakami E; Takeda T; Kokubu T
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S108-12. PubMed ID: 2454355
[TBL] [Abstract][Full Text] [Related]
2. Controlled-release carvedilol in the treatment of essential hypertension.
Weber MA; Sica DA; Tarka EA; Iyengar M; Fleck R; Bakris GL
Am J Cardiol; 2006 Oct; 98(7A):32L-38L. PubMed ID: 17023230
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of carvedilol in severe hypertension.
Ogihara T; Yoshinaga K; Kamahara Y; Ikeda M; Goto Y; Arakawa K; Iimura I; Ishii M; Kokubu T; Takeda T
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S69-72. PubMed ID: 1721983
[TBL] [Abstract][Full Text] [Related]
4. Circadian antihypertensive profile of carvedilol (BM 14190).
Meyer-Sabellek W; Schulte KL; Distler A; Gotzen R
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S119-23. PubMed ID: 2454357
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.
Ollivier JP; Durier P; Bussiere JL; Gayet JL
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S164-6. PubMed ID: 1974509
[TBL] [Abstract][Full Text] [Related]
6. Dose-effect relationship of carvedilol in essential hypertension. An open study.
Ogihara T; Goto Y; Yoshinaga K; Kumahara Y; Iimura O; Ishii M; Murakami E; Takeda T; Kokubu T; Arakawa K
Drugs; 1988; 36 Suppl 6():75-81. PubMed ID: 2908305
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
Lund-Johansen P; Omvik P; Nordrehaug JE; White W
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term carvedilol therapy on renal function in essential hypertension.
Tomita K; Marumo F
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S97-101. PubMed ID: 1378158
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study.
Galzerano D; Tammaro P; del Viscovo L; Lama D; Galzerano A; Breglio R; Tuccillo B; Paolisso G; Capogrosso P
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1563-9. PubMed ID: 16364826
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
Henderson LS; Tenero DM; Baidoo CA; Campanile AM; Harter AH; Boyle D; Danoff TM
Am J Cardiol; 2006 Oct; 98(7A):17L-26L. PubMed ID: 17023228
[TBL] [Abstract][Full Text] [Related]
11. Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study.
McPhillips JJ; Schwemer GT; Scott DI; Zinny M; Patterson D
Drugs; 1988; 36 Suppl 6():82-91. PubMed ID: 2908306
[TBL] [Abstract][Full Text] [Related]
12. Carvedilol for systemic hypertension.
Heber ME; Brigden GS; Caruana MP; Lahiri A; Raftery EB
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S113-8. PubMed ID: 2454356
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
15. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients.
Leonetti G; Sampieri L; Cuspidi C; Boselli L; Terzoli L; Rupoli L; Zanchetti A
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S94-6. PubMed ID: 2454377
[TBL] [Abstract][Full Text] [Related]
16. The safety of adding carvedilol to hypertensive patients inadequately treated with diuretics.
Dupont AG; Schoors DF; Venuti RP
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S153-7. PubMed ID: 1974507
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
Ruilope LM
Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of carvedilol in the treatment of hypertension.
Schnurr E; Widmann L; Glocke M
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S101-7. PubMed ID: 2454354
[TBL] [Abstract][Full Text] [Related]
19. A multicenter comparison of carvedilol with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension.
Langdon CG; Baxter GA; Young PH
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S51-6. PubMed ID: 1721980
[TBL] [Abstract][Full Text] [Related]
20. Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol.
Stoschitzky K; Stoschitzky G; Brussee H; Bonelli C; Dobnig H
Cardiology; 2006; 106(4):199-206. PubMed ID: 16679760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
